Domov › Rakovina močového mechúra › Pennsylvania › Philadelphia
Klinické štúdie Rakovina močového mechúra v meste Philadelphia, PA
21 štúdií pre Rakovina močového mechúra hľadá účastníkov v zariadeniach v meste Philadelphia a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Prebieha náborFáza 2
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 míľ odtiaľ
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
Prebieha nábor
- Abramson Cancer Center, Philadelphia
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Prebieha náborFáza 3
- Fox Chase Cancer Center, Philadelphia
- Fox Chase Cancer Center-Rockledge, Rockledge · 10 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 míľ odtiaľ
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Prebieha náborFáza 2
- MidLantic Urology ( Site 0102), Bala-Cynwyd · 5 míľ odtiaľ
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Prebieha náborFáza 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 míľ odtiaľ
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Prebieha náborFáza 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
Prebieha náborObservačná štúdia
- Research Site, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Prebieha nábor
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Prebieha náborFáza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Prebieha náborObservačná štúdia
- University of Pennsylvania, Philadelphia
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Prebieha náborFáza 2
- University of Pennsylvania, Philadelphia
- Midlantic Urology (Solaris), Bala-Cynwyd · 5 míľ odtiaľ
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Prebieha náborFáza 1
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Prebieha náborFáza 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 míľ odtiaľ
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 míľ odtiaľ
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Prebieha náborFáza 1/2
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Prebieha náborFáza 2
- Thomas Jefferson University, Philadelphia
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Prebieha náborFáza 1
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- University of Pennsylvania, Philadelphia
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Prebieha nábor
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Einstein Philadelphia Hospital, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Prebieha náborFáza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Philadelphia
Štúdie Rakovina močového mechúra v iných mestách
- New York City, NY35 štúdií
- Nashville, TN31 štúdií
- Houston, TX31 štúdií
- Dallas, TX27 štúdií
- Washington, DC26 štúdií
- Boston, MA26 štúdií
- Baltimore, MD24 štúdií
- Los Angeles, CA24 štúdií
- St. Louis, MO22 štúdií
- Seattle, WA21 štúdií
- Chicago, IL21 štúdií
- Edison, NJ21 štúdií
Iné štúdie v Philadelphia
- Rakovina (všetky typy)59 štúdií
- Rakovina prsníka56 štúdií
- Nemalobunkový karcinóm pľúc51 štúdií
- Metastatická rakovina46 štúdií
- Rakovina prostaty44 štúdií
- Kolorektálny karcinóm44 štúdií
- Rakovina vaječníkov44 štúdií
- Rakovina pľúc36 štúdií
- Akútna myeloidná leukémia34 štúdií
- Srdcové zlyhanie31 štúdií
- Rakovina endometria28 štúdií
- Depresia26 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.